NASDAQ:TELA | Free Cash Flow | TELA Bio, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$11.17M$119,000.00-$11.29M
2025-12-31-$4.87M$91,000.00-$4.96M
2025-03-31-$9.73M$32,000.00-$9.76M
2024-12-31-$7.53M$264,000.00-$7.8M
2024-03-31-$14.38M$304,000.00-$14.69M
2023-12-31-$11.05M$205,000.00-$11.26M
2023-03-31-$11.57M$115,000.00-$11.69M
2022-12-31-$10.98M$46,000.00-$11.03M
2022-03-31-$10.43M$336,000.00-$10.77M
2021-12-31-$9.59M$289,000.00-$9.88M
2021-03-31-$8.59M$22,000.00-$8.61M
2020-12-31-$7.1M$38,000.00-$7.14M
2020-03-31-$7.31M$68,000.00-$7.38M
2019-12-31-$7.18M$33,000.00-$7.22M
2019-03-31-$7.78M$48,000.00-$7.83M
2018-12-31-$5.76M$20,000.00-$5.78M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$28.22M$448,000.00-$28.67M
2024-12-31-$41.6M$989,000.00-$42.58M
2023-12-31-$40.86M$611,000.00-$41.47M
2022-12-31-$40.75M$872,000.00-$41.62M
2021-12-31-$30.43M$627,000.00-$31.06M
2020-12-31-$24.46M$167,000.00-$24.62M
2019-12-31-$25.52M$197,000.00-$25.72M
2018-12-31-$19.92M$62,000.00-$19.99M
2017-12-31-$16.37M$114,000.00-$16.48M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.